Anti-angiogenic therapy subsequent to adeno-associated-virus-mediated immunotherapy eradicates lymphomas that disseminate to the liver

This publication has 25 references indexed in Scilit:

• Long–Term Expression of Angiostatin Suppresses Metastatic Liver Cancer in Mice
  Hepatology, 2003
• Continuous Intravascular Secretion of Endostatin in Mice from Transduced Hematopoietic Stem Cells
  Molecular Therapy, 2002
• Unfulfilled Promise of Endostatin in a Gene Therapy-Xenotransplant Model of Human Acute Lymphocytic Leukemia
  Molecular Therapy, 2002
• Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression
  Cancer Gene Therapy, 2001
• Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes
  Gene Therapy, 2001
• Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy
  Gene Therapy, 2001
• CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice
  Human Gene Therapy, 2001
• Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity
  Gene Therapy, 1999
• Expression of MHC Class II and B7–1 and B7–2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cells
  Tissue Antigens, 1996
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993